{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:57:48Z","timestamp":1791284268381,"version":"4.1.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T00:00:00Z","timestamp":1236038400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00436-009-1371-7","type":"journal-article","created":{"date-parts":[[2009,3,2]],"date-time":"2009-03-02T13:15:51Z","timestamp":1235999751000},"page":"955-965","source":"Crossref","is-referenced-by-count":47,"title":["Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges"],"prefix":"10.1007","volume":"104","author":[{"given":"Rashad","family":"Abdul-Ghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naguiba","family":"Loutfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel El","family":"Sahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,3]]},"reference":[{"key":"1371_CR1","first-page":"295","volume":"30","author":"SS Abdel Aziz","year":"2000","unstructured":"Abdel Aziz SS, el-Badawy NM (2000) Experimental trials of an artemisinin derivative in treatment of Schistosoma mansoni infected mice. J Egypt Soc Parasitol 30:295\u2013303","journal-title":"J Egypt Soc Parasitol"},{"key":"1371_CR2","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1371\/journal.pmed.0040014","volume":"4","author":"MH Abdulla","year":"2007","unstructured":"Abdulla MH, Lim KC, Sajid M, Mckerrow JH, Caffrey CR (2007) Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PloS Med 4:e14","journal-title":"PloS Med"},{"key":"1371_CR3","first-page":"423","volume":"34","author":"AA Abo-Madyan","year":"2004","unstructured":"Abo-Madyan AA, Morsy TA, Motawea SM (2004) Efficacy of Myrrh in the treatment of schistosomiasis (haematobium and mansoni) in Ezbet El-Bakly, Tamyia Center, El-Fayoum Governorate, Egypt. J Egypt Soc Parasitol 34:423\u2013446","journal-title":"J Egypt Soc Parasitol"},{"key":"1371_CR4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1076\/phbi.39.2.127.6253","volume":"39","author":"F Badria","year":"2001","unstructured":"Badria F, Abou-Mohamad G, El-Mowafy A, Masoud A, Salama O (2001) Mirazid: a new schistosomicidal drug. Pharmaceut Biol 39:127\u2013131","journal-title":"Pharmaceut Biol"},{"key":"1371_CR5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4269\/ajtmh.2005.73.365","volume":"73","author":"R Barakat","year":"2005","unstructured":"Barakat R, Elmorshedy H, Fenwick A (2005) Efficacy of myrrh in the treatment of human schistosomiasis mansoni. Am J Trop Med Hyg 73:365\u2013367","journal-title":"Am J Trop Med Hyg"},{"key":"1371_CR6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0169-4758(97)01207-6","volume":"14","author":"NR Bergquist","year":"1998","unstructured":"Bergquist NR, Colley DG (1998) Schistosomiasis vaccines: research to development. Parasitol Today 14:99\u2013104","journal-title":"Parasitol Today"},{"key":"1371_CR7","doi-asserted-by":"crossref","first-page":"774","DOI":"10.4269\/ajtmh.2004.71.774","volume":"71","author":"R Bergquist","year":"2004","unstructured":"Bergquist R, Utzinger J, Cholett J, Xiao SH, Weiss NA, Tanner M (2004) Triggering of high-level resistance against Schistosoma mansoni reinfection by artemether in the mouse model. Am J Trop Med Hyg 71:774\u2013777","journal-title":"Am J Trop Med Hyg"},{"key":"1371_CR8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0035-9203(89)90720-7","volume":"83","author":"S Botros","year":"1989","unstructured":"Botros S, Soliman A, el-Gawhary N, Selim M, Guirguis N (1989) Effect of combined low dose praziquantel and oxamniquine on different stages of schistosome maturity. Trans R Soc Trop Med Hyg 83:86\u201389","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1371_CR9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4269\/ajtmh.2004.71.206","volume":"71","author":"S Botros","year":"2004","unstructured":"Botros S, William S, Ebeid F, Cioli D, Katz N, Day TA, Bennett JL (2004) Lack of evidence for an antischistosomal activity of myrrh in experimental animals. Am J Trop Med Hyg 71:206\u2013210","journal-title":"Am J Trop Med Hyg"},{"key":"1371_CR10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.2005.72.119","volume":"72","author":"S Botros","year":"2005","unstructured":"Botros S, Sayed H, El-Dusoki H, Sabry H, Rabie I, El-Ghannam M, Hassanein M, Abd El-Wahab Y, Engles D (2005) Efficacy of Mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households. Am J Trop Med Hyg 72:119\u2013123","journal-title":"Am J Trop Med Hyg"},{"key":"1371_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0166-6851(89)90001-7","volume":"34","author":"PJ Brindley","year":"1989","unstructured":"Brindley PJ, Strand M, Norden AP, Sher A (1989) Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens. Mol Biochem Parasitol 34:99\u2013108","journal-title":"Mol Biochem Parasitol"},{"key":"1371_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4049\/jimmunol.139.1.215","volume":"139","author":"PJ Brindley","year":"1987","unstructured":"Brindley PJ, Sher A (1987) The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. J Immunol 139:215\u2013220","journal-title":"J Immunol"},{"key":"1371_CR13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cbpa.2007.05.031","volume":"11","author":"CR Caffrey","year":"2007","unstructured":"Caffrey CR (2007) Chemotherapy of schistosomiasis: present and future. Curr Opin Chem Biol 11:433\u2013439","journal-title":"Curr Opin Chem Biol"},{"key":"1371_CR14","first-page":"422","volume":"80","author":"DJ Chen","year":"1980","unstructured":"Chen DJ, Fu LF, Shao PP, Wu FZ, Fan CZ, Shu H, Ren CS, Sheng XL (1980) Studies on antischistosomal activity of qinghaosu in experimental therapy. Zhong Hui Yi Xue Zha Zhi 80:422\u2013428","journal-title":"Zhong Hui Yi Xue Zha Zhi"},{"key":"1371_CR15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0001-706X(00)00122-4","volume":"77","author":"L Chitsulo","year":"2000","unstructured":"Chitsulo L, Engles D, Montresor A, Savioli L (2000) The global status of schistosomiasis and its control. Acta Trop 77:41\u201351","journal-title":"Acta Trop"},{"key":"1371_CR16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0163-7258(95)00026-7","volume":"68","author":"D Cioli","year":"1995","unstructured":"Cioli D, Pica-Mattoccia L, Archer S (1995) Antischistosomal drugs: past, present \u2026and future. Pharmacol Ther 68:35\u201385","journal-title":"Pharmacol Ther"},{"key":"1371_CR17","first-page":"165","volume":"32","author":"AM Creasey","year":"1986","unstructured":"Creasey AM, Taylor P, Thomas JE (1986) Dosage trial of a combination of oxamniquine and praziquantel in the treatment of schistosomiasis in Zimbabwean schoolchildren. Cent Afr J Med 32:165\u2013167","journal-title":"Cent Afr J Med"},{"key":"1371_CR18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-3156.1999.00444.x","volume":"4","author":"D Clercq De","year":"1999","unstructured":"De Clercq D, Vercruysse J, Picquet M, Shaw DJ, Diop M, Ly A, Gryseels B (1999) The epidemiology of a recent focus of mixed Schistosoma haematobium and Schistosoma mansoni infections around the \u2018Lac de Guiers\u2019 in the Senegal River Basin, Senegal. Trop Med Int Health 4:544\u2013550","journal-title":"Trop Med Int Health"},{"key":"1371_CR19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1365-3156.2000.00628.x","volume":"5","author":"D Clercq De","year":"2000","unstructured":"De Clercq D, Vercruysse J, Verle\u00b4 P, Kongs A, Diop M (2000) What is the effect of combining artesunate and praziquantel in the treatment of Schistosoma mansoni infections? Trop Med Int Health 5:744\u2013746","journal-title":"Trop Med Int Health"},{"key":"1371_CR20","first-page":"507","volume":"65","author":"MJ Doenhoff","year":"1988","unstructured":"Doenhoff MJ, Modha J, Lambertucci JR (1988) Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase. Immunol 65:507\u2013510","journal-title":"Immunol"},{"key":"1371_CR21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(02)00045-1","volume":"82","author":"D Engels","year":"2002","unstructured":"Engels D, Chitsulo L, Montresor A, Savioli L (2002) The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop 82:139\u2013146","journal-title":"Acta Trop"},{"key":"1371_CR22","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1017\/S003118200007534X","volume":"105","author":"PG Fallon","year":"1992","unstructured":"Fallon PG, Cooper RO, Probert AJ, Doenhoff MJ (1992) Immune-dependent chemotherapy of schistosomiasis. Parasitology 105:S41\u2013S48","journal-title":"Parasitology"},{"key":"1371_CR23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4269\/ajtmh.1995.53.61","volume":"53","author":"PG Fallon","year":"1995","unstructured":"Fallon PG, Sturrock RF, Niang AC, Doenhoff MJ (1995) Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am J Trop Med Hyg 53:61\u201362","journal-title":"Am J Trop Med Hyg"},{"key":"1371_CR24","first-page":"316","volume":"12","author":"PG Fallon","year":"1996","unstructured":"Fallon PG, Tao LF, Ismail MM, Bennett JL (1996a) Schistosome resistance to praziquantel: fact or artifact. Trends Parasitol 12:316\u2013320","journal-title":"Trends Parasitol"},{"key":"1371_CR25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1017\/S0031182000065069","volume":"112","author":"PG Fallon","year":"1996","unstructured":"Fallon PG, Fookes RE, Wharton GA (1996b) Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for Drug-antibody synergy. Parasitology 112:47\u201358","journal-title":"Parasitology"},{"key":"1371_CR26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/expr.1997.4149","volume":"86","author":"PG Fallon","year":"1997","unstructured":"Fallon PG, Mubarak JS, Fookes RE, Niang M, Butterworth AE, Sturrock RF, Doenhoff MJ (1997) Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates. Exp Parasitol 86:29\u201336","journal-title":"Exp Parasitol"},{"key":"1371_CR27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pt.2003.09.005","volume":"19","author":"A Fenwick","year":"2003","unstructured":"Fenwick A, Savioli L, Engels D, Bergquist NR, Todd MH (2003) Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol 19:509\u2013515","journal-title":"Trends Parasitol"},{"key":"1371_CR28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/00034983.1971.11686766","volume":"65","author":"R Foster","year":"1971","unstructured":"Foster R, Mesmer ET, Cheetham BL, King DF (1971) The control of immature Schistosoma mansoni in mice by UK 3883, a novel 2-aminomethyltetrahydroquinoline derivative. Ann Trop Med Parasitol 65:221\u2013232","journal-title":"Ann Trop Med Parasitol"},{"key":"1371_CR29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0091-3057(00)00309-9","volume":"67","author":"RF Genovese","year":"2000","unstructured":"Genovese RF, Newman DB, Brewer TG (2000) Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats. Pharmacol Biochem Behav 67:37\u201344","journal-title":"Pharmacol Biochem Behav"},{"key":"1371_CR30","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.ijpara.2006.07.011","volume":"36","author":"J Golenser","year":"2006","unstructured":"Golenser J, Waknine JH, Krugliak M, Hunt NH, Grau GE (2006) Current perspectives on the mechanism of action of artemisinins. Int J Parasitol 36:1427\u20131441","journal-title":"Int J Parasitol"},{"key":"1371_CR31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00389899","volume":"52","author":"R G\u00f6nnert","year":"1977","unstructured":"G\u00f6nnert R, Andrews P (1977) Praziquantel, a new broad-spectrum antischistosomal agent. Z Parasitenkd 52:129\u2013150","journal-title":"Z Parasitenkd"},{"key":"1371_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpara.2004.09.004","volume":"35","author":"RM Greenberg","year":"2005","unstructured":"Greenberg RM (2005) Are Ca2+ channels targets of praziquantel action? Int J Parasitol 35:1\u20139","journal-title":"Int J Parasitol"},{"key":"1371_CR33","first-page":"620","volume":"54","author":"DA Greene","year":"1993","unstructured":"Greene DA (1993) Gold, frankincense, myrrh, and medicine. N C Med J 54:620\u2013622","journal-title":"N C Med J"},{"key":"1371_CR34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0169-4758(99)01597-5","volume":"16","author":"B Gryseels","year":"2000","unstructured":"Gryseels B (2000) Schistosomiasis vaccines: a devils\u2019 advocate view. Parasitol Today 16:46\u201348","journal-title":"Parasitol Today"},{"key":"1371_CR35","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1046\/j.1365-3156.2001.00811.x","volume":"6","author":"B Gryseels","year":"2001","unstructured":"Gryseels B, Mbaye A, De Vlas SJ, Stelma FF, Guiss\u00e9 F, van Lieshout L, Faye D, Diop M, Ly A, Tchuem-Tchuent\u00e9 LA, Engels D, Polman K (2001) Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop Med Int Health 6:864\u2013873","journal-title":"Trop Med Int Health"},{"key":"1371_CR36","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","volume":"368","author":"B Gryseels","year":"2006","unstructured":"Gryseels B, Polman K, Clerinx J, Kestens L (2006) Human schistosomiasis. Lancet 368:1106\u20131118","journal-title":"Lancet"},{"key":"1371_CR37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1017\/S0031182000051568","volume":"93","author":"W Harnett","year":"1986","unstructured":"Harnett W, Kusel JR (1986) Increased exposure of parasite antigens at the surface of adult male Schistosoma mansoni exposed to praziquantel in vitro. Parasitology 93:401\u2013405","journal-title":"Parasitology"},{"key":"1371_CR38","first-page":"999","volume":"33","author":"M Hassan","year":"2003","unstructured":"Hassan M, El-Motaiem M, Afify H, Abaza B, El-Shafie M, Massoud AM (2003) In vitro effect of Mirazid on Schistosoma mansoni worms. J Egypt Soc Parasitol 33:999\u20131008","journal-title":"J Egypt Soc Parasitol"},{"key":"1371_CR39","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2307\/3279978","volume":"64","author":"GR Hillman","year":"1978","unstructured":"Hillman GR, Senft AW, Gibler WB (1978) The mode of action of hycanthone revisited. J Parasitol 64:754\u2013756","journal-title":"J Parasitol"},{"key":"1371_CR40","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1371\/journal.pmed.0030102","volume":"3","author":"PJ Hotez","year":"2006","unstructured":"Hotez PJ, Molyneux DH, Fenwick A, Ottessen E, Ehrlich Sachs S, Sachs JD (2006) Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV\/AIDS, tuberculosis, and malaria. PLoS Med 3:e102","journal-title":"PLoS Med"},{"key":"1371_CR41","first-page":"685","volume":"24","author":"MM Ismail","year":"1994","unstructured":"Ismail MM, Taha SA, Farghaly AM, el-Azony AS (1994) Laboratory induced resistance to praziquantel in experimental schistosomiasis. J Egypt Soc Parasitol 24:685\u2013695","journal-title":"J Egypt Soc Parasitol"},{"key":"1371_CR42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1996.55.214","volume":"55","author":"M Ismail","year":"1996","unstructured":"Ismail M, Metwally A, Farghaly A, Bruce J, Tao L-F, Bennett JL (1996) Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate highly doses of praziquantel. Am J Trop Med Hyg 55:214\u2013218","journal-title":"Am J Trop Med Hyg"},{"key":"1371_CR43","doi-asserted-by":"crossref","first-page":"932","DOI":"10.4269\/ajtmh.1999.60.932","volume":"60","author":"M Ismail","year":"1999","unstructured":"Ismail M, Botros S, Metwally A, William S, Farghaly A, Tao L-F, Day TA, Bennett JL (1999) Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg 60:932\u2013935","journal-title":"Am J Trop Med Hyg"},{"key":"1371_CR44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ijpara.2006.02.002","volume":"36","author":"MC Jeziorski","year":"2006","unstructured":"Jeziorski MC, Greenberg RM (2006) Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action. Int J Parasitol 36:625\u2013632","journal-title":"Int J Parasitol"},{"key":"1371_CR45","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1086\/504380","volume":"42","author":"P Kallestrup","year":"2006","unstructured":"Kallestrup P, Zinyama R, Gomo E, Butterworth AE, van Dam GJ, Gerstoft J, Erikstrup C, Ullum H (2006) Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection. Clin Infect Dis 42:1781\u20131789","journal-title":"Clin Infect Dis"},{"key":"1371_CR46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/106002808902300105","volume":"23","author":"S Kaojarern","year":"1989","unstructured":"Kaojarern S, Nathakarnkikool S, Suvanakoot U (1989) Comparative bioavailability of praziquantel tablets. DICP: The Annals of Pharmacotherapy 23:29\u201332","journal-title":"DICP: The Annals of Pharmacotherapy"},{"key":"1371_CR47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4269\/ajtmh.1998.59.307","volume":"59","author":"DM Karanja","year":"1998","unstructured":"Karanja DM, Boyer AE, Strand M, Colley DG, Nahlen BL, Ouma JH, Secor WE (1998) Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1. Am J Trop Med Hyg 59:307\u2013311","journal-title":"Am J Trop Med Hyg"},{"key":"1371_CR48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-4758(99)01421-0","volume":"15","author":"N Katz","year":"1999","unstructured":"Katz N (1999) Schistosomiasis vaccines: the need for more research before clinical trials. Parasitol Today 15:165\u2013166","journal-title":"Parasitol Today"},{"key":"1371_CR49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.actatropica.2008.05.006","volume":"108","author":"N Katz","year":"2008","unstructured":"Katz N, Coelho PMZ (2008) Clinical therapy of schistosomiasis mansoni: The Brazilian contribution. Acta Trop 108:72\u201378","journal-title":"Acta Trop"},{"key":"1371_CR50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1590\/S0037-86821973000600008","volume":"6","author":"N Katz","year":"1973","unstructured":"Katz N, Dias EP, Arau'jo N, Souza CP (1973) Estudo de uma cepa humana de Schistosoma mansoni resistente a agentes esquistossomicidas. Rev Soc Bras Med Trop 6:381\u2013387","journal-title":"Rev Soc Bras Med Trop"},{"key":"1371_CR51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/00034983.1976.11687128","volume":"70","author":"B Kaye","year":"1976","unstructured":"Kaye B, Woolhouse NM (1976) The metabolism of oxamniquine\u2014a new schistosomicide. Ann Trop Med Parasitol 70:323\u2013328","journal-title":"Ann Trop Med Parasitol"},{"key":"1371_CR52","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/jac\/dkl408","volume":"58","author":"J Keiser","year":"2006","unstructured":"Keiser J, Utzinger J, Tanner M, Dong Y, Vennerstrom JL (2006) The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica. J Antimicrob Chemother 58:1193\u20131197","journal-title":"J Antimicrob Chemother"},{"key":"1371_CR53","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","volume":"228","author":"DL Klayman","year":"1985","unstructured":"Klayman DL (1985) Qinghaosu (artemisinin): an antimalarial drug from China. Science 228:1049\u20131055","journal-title":"Science"},{"key":"1371_CR54","first-page":"359","volume":"68","author":"GO Kokwaro","year":"1991","unstructured":"Kokwaro GO, Taylor G (1991) Oxamniquine pharmacokinetics in healthy Kenyan African volunteers. East Afr Med J 68:359\u2013364","journal-title":"East Afr Med J"},{"key":"1371_CR55","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1371\/journal.pmed.0040206","volume":"4","author":"AN Kuntz","year":"2007","unstructured":"Kuntz AN, Davioud-Charvete E, Sayed AA, Califf LL, Dessolin J, Arn\u00e9r ESJ, Williams DL (2007) Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PloS Med 4:e206","journal-title":"PloS Med"},{"key":"1371_CR56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/S0074-02762006000900046","volume":"101","author":"JR Kusel","year":"2006","unstructured":"Kusel JR, Oliveira FA, Todd M, Ronketti F, Lima SF, Mattos AC, Reis KT, Ceolho PM, Thornhill JA, Ribeiro F (2006) The effects of drugs, ions, and poly-l-lysine on the excretory system of Schistosoma mansoni. Mem Inst Oswaldo Cruz 101:293\u2013298","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1371_CR57","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0035-9203(89)90505-1","volume":"83","author":"JR Lambertucci","year":"1989","unstructured":"Lambertucci JR, Modha J, Doenhoff MJ (1989) Schistosoma mansoni: the therapeutic efficacy of oxamniquine is enhanced by immune serum. Trans R Soc Trop Med Hyg 83:362\u2013363","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1371_CR58","first-page":"187","volume":"17","author":"WJ Le","year":"1982","unstructured":"Le WJ, You JQ, Yang YQ, Mei JY, Guo HF, Yang HZ, Zhang CW (1982) Studies on the efficacy of artemether in experimental schistosomiasis. Acta Pharm Sin 17:187\u2013193","journal-title":"Acta Pharm Sin"},{"key":"1371_CR59","first-page":"619","volume":"18","author":"WJ Le","year":"1983","unstructured":"Le WJ, You JQ, Mei JY (1983) Chemotherapeutic effect of artesunate in experimental schistosomiasis. Acta Pharm Sin 18:619\u2013621","journal-title":"Acta Pharm Sin"},{"key":"1371_CR60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1645\/GE-322R","volume":"91","author":"MR Mahmoud","year":"2005","unstructured":"Mahmoud MR, Botros SS (2005) Artemether as adjuvant therapy to praziquantel in murine Egyptian schistosomiasis mansoni. J Parasitol 91:175\u2013178","journal-title":"J Parasitol"},{"key":"1371_CR61","first-page":"544","volume":"31","author":"H Mehlhorn","year":"1981","unstructured":"Mehlhorn H, Becker B, Andrews P, Thomas H, Frenkel JK (1981) In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. (A light and electron microscopic study). Arzneim Forsch\/Drug Res 31:544\u2013554","journal-title":"Arzneim Forsch\/Drug Res"},{"key":"1371_CR62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-3024.1990.tb00958.x","volume":"12","author":"J Modha","year":"1990","unstructured":"Modha J, Lambertucci JR, Doenhoff MJ, McLaren DJ (1990) Immune dependence of schistosomicidal chemotherapy: an ultrastructural study of Schistosoma mansoni adult worms exposed to praziquantel and immune serum in vivo. Parasite Immunol 12:321\u2013334","journal-title":"Parasite Immunol"},{"key":"1371_CR63","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00389900","volume":"52","author":"J Pellegrino","year":"1977","unstructured":"Pellegrino J, Lima-Costa FF, Carlos MA, Mello RT (1977) Experimental chemotherapy of schistosomiasis mansoni. XIII. Activity of praziquantel, an isoquinoline-pyrazino derivative, on mice, hamsters and Cebus monkeys. Z Parasitenkd 52:151\u2013168","journal-title":"Z Parasitenkd"},{"key":"1371_CR64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S003118209800273X","volume":"117","author":"C Pereira","year":"1998","unstructured":"Pereira C, Fallon PG, Cornette J, Capron A, Doenhoff MJ, Pierce RJ (1998) Alterations in cytochrome-c oxidase expression between praziquantel-resistant and susceptible strains of Schistosoma mansoni. Parasitology 117:63\u201373","journal-title":"Parasitology"},{"key":"1371_CR65","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2307\/3281503","volume":"72","author":"L Pica-Mattoccia","year":"1986","unstructured":"Pica-Mattoccia L, Cioli D (1986) Lack of correlation between schistosomicidal and anticholinergic properties of hycanthone and related drugs. J Parasitol 72:531\u2013539","journal-title":"J Parasitol"},{"key":"1371_CR66","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0035-9203(89)90508-7","volume":"83","author":"L Pica-Mattoccia","year":"1989","unstructured":"Pica-Mattoccia L, Cioli D, Archer S (1989) Binding of oxamniquine to the DNA of schistosomes. Trans R Soc Trop Med Hyg 83:373\u2013376","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1371_CR67","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1006\/expr.1993.1104","volume":"77","author":"L Pica-Mattoccia","year":"1993","unstructured":"Pica-Mattoccia L, Dias LCD, Moroni R, Cioli D (1993) Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone\/oxamniquine-resistant strains are mutated in the same gene. Exp Parasitol 77:445\u2013449","journal-title":"Exp Parasitol"},{"key":"1371_CR68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1590\/S0074-02762006000900048","volume":"101","author":"L Pica-Mattoccia","year":"2006","unstructured":"Pica-Mattoccia L, Carlini D, Guidi A, Cimica V, Vigorosi F, Cioli D (2006) The schistosome enzyme that activates oxamniquine has the characteristics of a sulfotransferase. Mem Inst Oswaldo Cruz 101:307\u2013312","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1371_CR69","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.exppara.2006.09.017","volume":"115","author":"L Pica-Mattoccia","year":"2007","unstructured":"Pica-Mattoccia L, Valle C, Basso A, Troiani AR, Vigorosi F, Liberti P, Festucci A, Cioli D (2007) Cytochalasin D abolishes the schistosomicidal activity of praziquantel. Exp Parasitol 115:344\u2013351","journal-title":"Exp Parasitol"},{"key":"1371_CR70","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0035-9203(98)90971-3","volume":"92","author":"M Picquet","year":"1998","unstructured":"Picquet M, Vercruysse J, Shaw DJ, Diop M, Ly A (1998) Efficacy of praziquantel against Schistosoma mansoni in northern Senegal. Trans R Soc Trop Med Hyg 92:90\u201393","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1371_CR71","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4269\/ajtmh.1999.60.547","volume":"60","author":"R Price","year":"1999","unstructured":"Price R, van Vugt M, Phaipun L, Luxemburger C, Simpson J, McGready R, ter Kuile F, Kham A, Chongsuphajaisiddhi T, White NJ, Nosten F (1999) Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg 60:547\u2013555","journal-title":"Am J Trop Med Hyg"},{"key":"1371_CR72","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/bmj.287.6396.877","volume":"287","author":"RN Pugh","year":"1983","unstructured":"Pugh RN, Teesdale CH (1983) Synergy of concurrent low dose oxamniquine and praziquantel in schistosomiasis. Br Med J 287:877\u2013878","journal-title":"Br Med J"},{"key":"1371_CR73","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S0031182097002291","volume":"116","author":"F Ribeiro","year":"1998","unstructured":"Ribeiro F, Coelho PM, Vieira LQ, Watson DG, Kusel JR (1998) The effect of praziquantel treatment on glutathione concentration in Schistosoma mansoni. Parasitology 116:229\u2013236","journal-title":"Parasitology"},{"key":"1371_CR74","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1590\/S0036-46652004000400010","volume":"46","author":"F Ribeiro","year":"2004","unstructured":"Ribeiro F, Mello RT, Tavares CA, Kusel JR, Coelho PM (2004) Synergistic action of praziquantel and host specific immune response against Schistosoma mansoni at different phases of infection. Rev Inst Med Trop Sao Paulo 46:231\u2013233","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"1371_CR75","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/222581a0","volume":"222","author":"HC Richards","year":"1969","unstructured":"Richards HC, Foster R (1969) A new series of 2-aminomethyltetrahydroquinoline derivatives displaying schistosomicidal activity in rodents and primates. Nature 222:581\u2013582","journal-title":"Nature"},{"key":"1371_CR76","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nm1737","volume":"14","author":"AA Sayed","year":"2008","unstructured":"Sayed AA, Simeonov A, Thomas CJ, Inglese J, Ausin CP, Williams DL (2008) Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat Med 14:407\u2013412","journal-title":"Nat Med"},{"key":"1371_CR77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0035-9203(83)90008-1","volume":"77","author":"JR Shaw","year":"1983","unstructured":"Shaw JR, Brammer KW (1983) The treatment of experimental schistosomiasis with a combination of oxamniquine and praziquantel. Trans R Soc Trop Med Hyg 77:39\u201340","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1371_CR78","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4269\/ajtmh.2001.65.700","volume":"65","author":"Z Sheir","year":"2001","unstructured":"Sheir Z, Nasr AA, Massoud A, Salama O, Badra GA, El-Shennawy H, Hassan N, Hammad SM (2001) A safe, effective, herbal antischistosomal therapy derived from myrrh. Am J Trop Med Hyg 65:700\u2013704","journal-title":"Am J Trop Med Hyg"},{"key":"1371_CR79","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF00931694","volume":"78","author":"U Staudt","year":"1992","unstructured":"Staudt U, Schmahl G, Blaschke G, Mehlhorn H (1992) Light and scanning electron microscopy studies on the effects of the enantiomers of praziquantel and its main metabolite on Schistosoma mansoni in vitro. Parasitol Res 78:392\u2013397","journal-title":"Parasitol Res"},{"key":"1371_CR80","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","volume":"6","author":"P Steinmann","year":"2006","unstructured":"Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systematic review, meta-analysis and estimates of people at risk. Lancet Infect Dis 6:411\u2013425","journal-title":"Lancet Infect Dis"},{"key":"1371_CR81","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4269\/ajtmh.1995.53.167","volume":"53","author":"FF Stelma","year":"1995","unstructured":"Stelma FF, Talla I, Sow S, Kongs A, Niang M, Polman K, Deelder AM, Gryseels B (1995) Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am J Trop Med Hyg 53:167\u2013170","journal-title":"Am J Trop Med Hyg"},{"key":"1371_CR82","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.2042-7158.1990.tb07030.x","volume":"42","author":"HA Titulaer","year":"1990","unstructured":"Titulaer HA, Zuidema J, Kager PA, Wetsteyn JC, Lugt CB, Merkus FW (1990) The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers. J Pharm Pharmacol 42:810\u2013813","journal-title":"J Pharm Pharmacol"},{"key":"1371_CR83","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0140-6736(00)02114-0","volume":"355","author":"J Utzinger","year":"2000","unstructured":"Utzinger J, N\u2019Goran EK, N\u2019Dri A, Lengeler C, Xiao SH, Tanner M (2000) Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet 355:1320\u20131325","journal-title":"Lancet"},{"key":"1371_CR84","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0001-706X(01)00138-3","volume":"80","author":"J Utzinger","year":"2001","unstructured":"Utzinger J, Chollet J, You J, Mei J, Tanner M, Xiao S (2001a) Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals. Acta Trop 80:9\u201318","journal-title":"Acta Trop"},{"key":"1371_CR85","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2174\/0929867013371581","volume":"8","author":"J Utzinger","year":"2001","unstructured":"Utzinger J, Xiao S, Keiser J, Chen M, Zheng J, Tanner M (2001b) Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites. Curr Med Chem 8:1841\u20131860","journal-title":"Curr Med Chem"},{"key":"1371_CR86","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0020-7519(01)00297-1","volume":"31","author":"J Utzinger","year":"2001","unstructured":"Utzinger J, Xiao SH, N\u2019Goran EK, Bergquist R, Tanner M (2001c) The potential of artemether for the control of schistosomiasis. Int J Parasitol 31:1549\u20131562","journal-title":"Int J Parasitol"},{"key":"1371_CR87","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0035-9203(02)90110-0","volume":"96","author":"J Utzinger","year":"2002","unstructured":"Utzinger J, Chollet J, Tu Z, Xiao S, Tanner M (2002) Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice. Trans R Soc Trop Med Hyg 96:318\u2013323","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1371_CR88","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/AAC.47.5.1487-1495.2003","volume":"47","author":"J Utzinger","year":"2003","unstructured":"Utzinger J, Keiser J, Xiao SH, Tanner M, Singer BH (2003) Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother 47:1487\u20131495","journal-title":"Antimicrob Agents Chemother"},{"key":"1371_CR89","first-page":"105","volume":"8","author":"J Utzinger","year":"2007","unstructured":"Utzinger J, Xiao SH, Tanner M, Keiser J (2007) Artemisinins for schistosomiasis and beyond. Curr Opin Investig Drugs 8:105\u2013116","journal-title":"Curr Opin Investig Drugs"},{"key":"1371_CR90","doi-asserted-by":"crossref","first-page":"760","DOI":"10.4269\/ajtmh.1999.61.760","volume":"61","author":"L Lieshout van","year":"1999","unstructured":"van Lieshout L, Stelma FF, Guisse F, Falcao Ferreira ST, Polman K, van Dam GJ, Diakhate M, Sow S, Deelder A, Gryseels B (1999) The contribution of host-related factors to low cure rates of praziquantel for the treatment of Schistosoma mansoni in Senegal. Am J Trop Med Hyg 61:760\u2013765","journal-title":"Am J Trop Med Hyg"},{"key":"1371_CR91","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nature02779","volume":"430","author":"JL Vennerstrom","year":"2004","unstructured":"Vennerstrom JL, Arbe-Barnes S, Brun R, Charman SA, Chiu FCK, Chollet J, Dong Y, Dorn A, Hunziker D, Matile H, McIntosh K, Padmanilayam M, Santo Tomas J, Scheurer C, Scorneaux B, Tang Y, Urwyler H, Wittlin S, Charman WN (2004) Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 430:900\u2013904","journal-title":"Nature"},{"key":"1371_CR92","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00389901","volume":"52","author":"G Webbe","year":"1977","unstructured":"Webbe G, James C (1977) A comparison of the susceptibility to praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei in hamsters. Z Parasitenkd 52:169\u2013177","journal-title":"Z Parasitenkd"},{"key":"1371_CR93","first-page":"966","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"LT Webster Jr","year":"1990","unstructured":"Webster LT Jr (1990) Drugs used in the chemotherapy of helminthiasis. In: Gilman AG, Rall TA, Nies AS, Taylor P (eds) Goodman & Gilman\u2019s the pharmacological basis of therapeutics, 8th edn. Pergamon, New York, pp 966","edition":"8"},{"key":"1371_CR94","unstructured":"WHO (2001) Antimalarial drug combination therapy. Report of a WHO Technical Consultation (document WHO\/CDS\/RBM\/2001.35)"},{"key":"1371_CR95","unstructured":"WHO (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Tech Rep Ser No. 912"},{"key":"1371_CR96","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/infdis\/159.3.589","volume":"159","author":"SH Xiao","year":"1989","unstructured":"Xiao SH, Catto BA (1989a) Comparative in vitro and in vivo activity of racemic praziquantel and its levorotated isomer on Schistosoma mansoni. J Infect Dis 159:589\u2013592","journal-title":"J Infect Dis"},{"key":"1371_CR97","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1128\/AAC.33.9.1557","volume":"33","author":"SH Xiao","year":"1989","unstructured":"Xiao SH, Catto BA (1989b) In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Antimicrob Agents Chemother 33:1557\u20131562","journal-title":"Antimicrob Agents Chemother"},{"key":"1371_CR98","first-page":"161","volume":"27","author":"SH Xiao","year":"1992","unstructured":"Xiao SH, Yin JW, Mei JY, You JQ, Li Y, Jiang HJ (1992) Effect of arteether on Schistosoma japonicum. Acta Pharm Sin 27:161\u2013165","journal-title":"Acta Pharm Sin"},{"key":"1371_CR99","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0035-9203(99)90039-1","volume":"93","author":"SH Xiao","year":"1999","unstructured":"Xiao SH, Chollet J, Booth M, Weiss NA, Tanner M (1999) Therapeutic effect of praziquantel enantiomers in mice infected with Schistosoma mansoni. Trans R Soc Trop Med Hyg 93:324\u2013325","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1371_CR100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0169-4758(99)01601-4","volume":"16","author":"SH Xiao","year":"2000","unstructured":"Xiao SH, Booth M, Tanner M (2000a) The prophylactic effects of artemether against Schistosoma japonicum infections. Parasitol Today 16:122\u2013126","journal-title":"Parasitol Today"},{"key":"1371_CR101","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1383-5769(00)00028-3","volume":"49","author":"SH Xiao","year":"2000","unstructured":"Xiao SH, Chollet J, Weiss NA, Bergquist RN, Tanner M (2000b) Preventive effect of artemether in experimental animals infected with Schistosoma mansoni. Parasitol Int 49:19\u201324","journal-title":"Parasitol Int"},{"key":"1371_CR102","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0001-706X(00)00067-X","volume":"75","author":"SH Xiao","year":"2000","unstructured":"Xiao SH, Binggui S, Chollet J, Tanner M (2000c) Tegumental changes in 21-day-old Schistosoma mansoni harboured in mice treated with artemether. Acta Trop 75:341\u2013348","journal-title":"Acta Trop"},{"key":"1371_CR103","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0035-9203(01)90336-0","volume":"95","author":"SH Xiao","year":"2001","unstructured":"Xiao SH, Chollet J, Utzinger J, Matile H, Mei J, Tanner M (2001) Artemether administered together with haemin damages schistosomes in vitro. Trans R Soc Trop Med Hyg 95:67\u201371","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1371_CR104","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0001-706X(02)00009-8","volume":"82","author":"SH Xiao","year":"2002","unstructured":"Xiao SH, Tanner M, N\u2019Goran EK, Utzinger J, Chollet J, Bergquist R, Chen M, Zheng J (2002a) Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop 82:175\u2013181","journal-title":"Acta Trop"},{"key":"1371_CR105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.2002.66.30","volume":"66","author":"S Xiao","year":"2002","unstructured":"Xiao S, Yang Y, You Q, Utzinger J, Guo H, Peiying J, Mei J, Guo J, Bergquist R, Tanner M (2002b) Potential long-term toxicity of repeated orally administered doses of artemether in rats. Am J Trop Med Hyg 66:30\u201334","journal-title":"Am J Trop Med Hyg"},{"key":"1371_CR106","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1128\/AAC.01537-06","volume":"51","author":"SH Xiao","year":"2007","unstructured":"Xiao SH, Keiser J, Chollet J, Utzinger J, Dong Y, Endriss Y, Vennerstrom JL, Tanner M (2007) In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. Antimicrob Agents Chemother 51:1440\u20131445","journal-title":"Antimicrob Agents Chemother"},{"key":"1371_CR107","first-page":"251","volume":"10","author":"M Xu","year":"1998","unstructured":"Xu M (1998) The progress on prophylactic studies of artemisinin, artemether and artesunate against schistosomiasis japonica. Chin J Schistosomiasis Control 10:251\u2013253","journal-title":"Chin J Schistosomiasis Control"},{"key":"1371_CR108","first-page":"478","volume":"12","author":"JW Yin","year":"1991","unstructured":"Yin JW, Yang YQ, Xiao SH, Li Y, Jiang HJ (1991) Comparative studies on histological and histochemical alterations of Schistosoma japonicum induced by arteether and artemether. Acta Pharm Sin 12:478\u2013480","journal-title":"Acta Pharm Sin"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-009-1371-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-009-1371-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-009-1371-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T06:27:09Z","timestamp":1684909629000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-009-1371-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,3]]},"references-count":108,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["1371"],"URL":"https:\/\/doi.org\/10.1007\/s00436-009-1371-7","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,3]]}}}